1.0
Oct 18, 2023
Former employee, more than 3 years
Recommend
CEO approval
Business Outlook
Pros
marginally competitive salaries and a plethora of online tools.
Cons
C-suite inserted from Dexcom seems to ram an agenda that will not fit the acute cardiac monitoring space. Rampant nepotism, and unethical behavior going unchecked from every member of c-suite. C-suite does not seem competent to lead and protect investor value. Unless you are former Dexcom everyone is assumed to have a target on their back. Corporation's revised strategy viewed widely as a failure, which only bankrupts the corporate culture further.